| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/02/2023 | — | Keefe, Bruyette & Woods | Upgrades | Market Perform → Outperform | |
| 07/31/2023 | 23.66% | Piper Sandler | $19 → $23 | Maintains | Overweight |
| 07/11/2023 | 2.15% | Piper Sandler | → $19 | Assumes | → Overweight |
| 06/21/2023 | 34.41% | DA Davidson | → $25 | Initiates Coverage On | → Buy |
| 12/19/2022 | 55.91% | Keefe, Bruyette & Woods | → $29 | Initiates Coverage On | → Market Perform |
| 07/12/2022 | 18.28% | Piper Sandler | → $22 | Initiates Coverage On | → Overweight |
What is the target price for California Bancorp (CALB)?
The latest price target for California Bancorp (NASDAQ: CALB) was reported by Keefe, Bruyette & Woods on August 2, 2023. The analyst firm set a price target for $0.00 expecting CALB to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for California Bancorp (CALB)?
The latest analyst rating for California Bancorp (NASDAQ: CALB) was provided by Keefe, Bruyette & Woods, and California Bancorp upgraded their outperform rating.
When is the next analyst rating going to be posted or updated for California Bancorp (CALB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of California Bancorp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for California Bancorp was filed on August 2, 2023 so you should expect the next rating to be made available sometime around August 2, 2024.
Is the Analyst Rating California Bancorp (CALB) correct?
While ratings are subjective and will change, the latest California Bancorp (CALB) rating was a upgraded with a price target of $0.00 to $0.00. The current price California Bancorp (CALB) is trading at is $18.60, which is out of the analyst's predicted range.